NEW YORK, Feb. 10 (GenomeWeb News) - Orchid BioSciences today said that it has converted all of its outstanding convertible preferred stock into common stock as the first step in a broader effort to restructure its capital position.

As a result of the preferred stock conversion, Orchid had around 94.7 million common shares outstanding as of Feb. 9.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.